 |
Amgen is a leading human therapeutics company in the biotechnology industry. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.
www.amgen.com
|
|
 |
Astellas is a global pharmaceutical company based in Japan. Its aim is to contribute to better health for everyone by developing innovative and useful pharmaceuticals and delivering them to patients around the world.
www.astellas.com
|
|
 |
Avanir Pharmaceuticals is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. These products treat central nervous system disorders, inflammation and infectious disease.
www.avanir.com
|
|
 |
Biogen Idec is the third largest biopharmaceutical company in the world, involved with the discovery, development, manufacturing and commercialization of innovative therapies. Its products address diseases such as multiple sclerosis and the multiple challenges of oncology.
www.biogenidec.com
|
|
 |
Boston Scientific is the world’s largest medical device company dedicated to less-invasive medicine. The company provides a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties.
www.bostonscientific.com
|
|
 |
Biomarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Among the special areas of achievements is treating mucopolysaccharidosis VI (MPS VI) and mucopolysaccharidosis I (MPS I).
www.biomarinpharm.com
|
|
 |
Cephalon is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. www.cephalon.com
|
|
 |
Cubist Pharmaceuticals is a biopharmaceutical company focusing on the research, development and commercialization of pharmaceutical products directed towards the acute care environment.
www.cubist.com
|
|
 |
Eisai Inc. is a wholly-owned subsidiary of Eisai Corporation of North America. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies. Eisai Inc.'s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world
www.eisai.com
|
|
 |
Ipsen is an international pharmaceutical group specializing in targeted therapeutic areas, mainly oncology, endocrinology and neuromuscular disorders. It has R&D centers in Boston, London, Paris and Barcelona.
www.ipsen.com
|
|
 |
Lundbeck Inc. (formerly Ovation Pharmaceuticals, Inc.) is a company located in Deerfield, Illinois, that was established in March 2009 following the acquisition of Ovation Pharmaceuticals, Inc. by H. Lundbeck A/S an international pharmaceutical company specializing in central nervous system (CNS) disorders. With a portfolio of 20 high-need therapies and a pipeline of promising new drugs, Lundbeck is one of the fastest growing pharmaceutical companies in the United States.
www.lundbeckinc.com
|
|
 |
Nycomed is a Danish pharmaceutical company serving hospitals, specialists and general practitioners, as well as OTC medicines in selected markets. Its fields include cardiology, gastroenterology, osteoporosis, respiratory, pain and tissue management.
www.nycomed.com
|
|
 |
Shire is a global specialty biopharmaceutical company serving the consultant physician. It focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. Shire acquired Transkarvotic Therapies Inc (TKT) in 2005 and the new company is called Shire Human Genetic Therapies.
www.shire.com
|
|
 |
Takeda the largest pharmaceutical company in Japan and one of the global leaders of the industry. Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals.
www.takeda.com
|
|
 |
Tercica is a biopharmaceutical company committed to improving endocrine health by partnering with the endocrine community to develop and commercialize new therapeutics for short stature and other metabolic disorders.
www.tercica.com
|
|
 |
The Medicines Company, based in the USA, delivers innovative, cost-effective acute care products in the worldwide hospital marketplace.
www.themedicinescompany.com
|
|
 |
AutoGenomics Inc., based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. www.autogenomics.com
|
|
 |
BioGenex is a leading company in the field of cellular and molecular pathology products. BioGenex offers a broad range of reagents, detection kits, antibodies, probes, special stains and automated staining and imaging systems. BioGenex enables total solutions for the clinical and diagnostic applications and supports translational and molecular discovery research.
www.biogenex.com
|
|
 |
Cepheid is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures.
www.cepheid.com
|
|
 |
chemagen Biopolymer-Technologie AG is a key player in the field of automated nucleic acid isolation. chemagen offers a benchtop walk-away instrument relying upon the proven separation process for up to 600 µl blood and 1 - 12 samples in parallel. Outstanding robustness, minimal hands on time and fast automated applications translate to the highest throughput and flexibility of the laboratory workflow.
www.chemagen.com
|
|
 |
Siemens With the acquisition of Diagnostics Products Corporation, Bayer Diagnostics and Dade Behring, Siemens Medical Solutions has bridged the gap between in-vivo and in-vitro diagnostics to become the first full service diagnostics company. By bringing together medical imaging, laboratory diagnostics and healthcare information technology, Siemens offers a unique set of solutions that provide improved clinical, operational and financial outcomes. Medison Pharmatope continues to distribute and support the Diagnostic Products Corporation's products in all the user labs in Israel.
www.siemens.com
|
|
